Monthly Notification of Generic Drug and Biosimilar Substitutions:
DOH Guidance for Industry: Authorized Generics and Unbranded Biologics – Exclusion from the Hawaii List of Equivalent Generic Drug Products and Interchangeable Biological Products (June 2022)
